To view this email as a web page, click here.
 
PHARMACISTS' REPORT
Full Extent of Antibiotic Use in the US?
What we know—and what we don't—about antibiotic prescribing rates.
Read more
 
ADVERTISEMENT
Advertisement
EpiPen Recall Hits Home
This recall is a new headache in a long string of problems for Mylan.
Read more
 
ADVERTISEMENT
 
GSK Issues Voluntary Recall
Why nearly 600,000 inhalers are being recalled.
Read more
 
Alzheimer's Disease: Untapped Potential for Pharmacy
How pharmacists can become the perfect partner in the battle against Alzheimer's disease.
Read more
 
ADVERTISEMENT
Asembia1: The next generation of specialty pharmacy technology
The flexible design of Asembia's integrated, web-based system mimics pharmacy workflow to streamline clinical patient management, prior authorizations, prescription transfers, dynamic reporting, pharma/biotech programs, and more. For more information, visit www.asembia1.com
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.